Literature DB >> 26876636

The clinical significance of para-aortic nodal dissection for advanced gastric cancer.

S Morita1, T Fukagawa2, H Fujiwara1, H Katai1.   

Abstract

BACKGROUND: Advanced gastric cancer with the risk of extensive nodal involvement has a poor prognosis even after radical surgery. We aimed to comprehensively review the clinical significance of extended radical dissection.
METHODS: Between 1990 and 1999, 232 patients underwent radical gastrectomy with D2 plus para-aortic lymph node dissection at the National Cancer Center Hospital in Tokyo. We analyzed the short-term surgical and long-term oncological outcomes of these operations.
RESULTS: Major complications occurred in 34 patients (14.7%). Median operation time was 325 min (range: 182-555) and median blood loss was 715 ml (range: 95-4457). There were 2 (0.9%) hospital deaths. Nodal involvement of the para-aortic area was seen in 33 patients (14.2%). The overall 5- and 10-year survival rates in patients with para-aortic node involvement were 21.2 and 15.2%, respectively. Multivariate analysis of patients with para-aortic node involvement revealed advanced age and metastasis in the interaorticocaval lymph nodes above the left renal vein to be independent risk factors impacting overall survival.
CONCLUSIONS: PAN dissection has limited applicability and effectiveness to the patients with advanced gastric cancer. Above all, advanced age and metastasis in the interaorticocaval lymph nodes above the left renal vein are significant poor prognostic factor even after radical resection.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Advanced gastric cancer; Para-aortic lymph node; Prognosis

Mesh:

Year:  2016        PMID: 26876636     DOI: 10.1016/j.ejso.2016.01.002

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  8 in total

Review 1.  Distant nodal metastasis: is it always an unresectable disease?

Authors:  Gian Luca Baiocchi; Andrea Celotti; Sarah Molfino; Paolo Baggi; Antonio Tarasconi; Gianluca Baronio; Luca Arru; Federico Gheza; Guido Tiberio; Nazario Portolani
Journal:  Transl Gastroenterol Hepatol       Date:  2017-01-05

Review 2.  Clinical impact of molecular classifications in gastric cancer.

Authors:  Daniele Marrelli; Karol Polom; Alessandro Neri; Franco Roviello
Journal:  Updates Surg       Date:  2018-05-23

Review 3.  Para-aortic lymphadenectomy in surgery for gastric cancer: current indications and future perspectives.

Authors:  Valentina Mengardo; Maria Bencivenga; Jacopo Weindelmayer; Michele Pavarana; Simone Giacopuzzi; Giovanni de Manzoni
Journal:  Updates Surg       Date:  2018-05-30

Review 4.  Recent trends from the results of clinical trials on gastric cancer surgery.

Authors:  Takashi Kiyokawa; Takeo Fukagawa
Journal:  Cancer Commun (Lond)       Date:  2019-03-27

Review 5.  Current status of extended 'D2 plus' lymphadenectomy in advanced gastric cancer.

Authors:  Jing-Quan Li; Donglei He; Yue-Xiang Liang
Journal:  Oncol Lett       Date:  2021-04-12       Impact factor: 2.967

6.  Novel Drug Delivery Method Targeting Para-Aortic Lymph Nodes by Retrograde Infusion of Paclitaxel into Pigs' Thoracic Duct.

Authors:  Akira Saito; Natsuka Kimura; Yuji Kaneda; Hideyuki Ohzawa; Hideyo Miyato; Hironori Yamaguchi; Alan Kawarai Lefor; Ryozo Nagai; Naohiro Sata; Joji Kitayama; Kenichi Aizawa
Journal:  Cancers (Basel)       Date:  2022-08-01       Impact factor: 6.575

7.  Prognostic impact of D2-plus lymphadenectomy and optimal extent of lymphadenectomy in advanced gastric antral carcinoma: Propensity score matching analysis.

Authors:  Weilin Sun; Jingyu Deng; Nannan Zhang; Huifang Liu; Jinyuan Liu; Pengfei Gu; Yingxin Du; Zizhen Wu; Wenting He; Pengliang Wang; Han Liang
Journal:  Chin J Cancer Res       Date:  2020-02       Impact factor: 5.087

8.  Current status of lymph node dissection in gastric cancer.

Authors:  Bin Ke; Han Liang
Journal:  Chin J Cancer Res       Date:  2021-04-30       Impact factor: 5.087

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.